title: Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib.
authors.forename: James M
authors.initials: JM
authors.lastname: Cleary
authors.forename: Peter M
authors.initials: PM
authors.lastname: Sadow
authors.forename: Gregory W
authors.initials: GW
authors.lastname: Randolph
authors.forename: Edwin L
authors.initials: EL
authors.lastname: Palmer
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Lynch
authors.forename: Yuri E
authors.initials: YE
authors.lastname: Nikiforov
authors.forename: Lori J
authors.initials: LJ
authors.lastname: Wirth
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib